News

These stocks rose 700% in just a few days. Do you have them in your portfolio?

BY xlubecx Calender Icon11 June 2025
This company's stock rose 700%

Healthcare technology company Know Labs (NYSE: KNW) shares are experiencing exceptional growth after the announcement of its parent company’s acquisition by investment fund Goldeneye 1995 LLC. As reported by Finbold magazine, this transaction was financed primarily through Bitcoin and triggered an immediate market reaction.

Know Labs Shares Hit 700% Thanks to Bitcoin Transaction

Highest trading levels since March 2025

Know Labs (KNW) shares, according to TradingView data, recorded a steep increase of 700% over several days. The price climbed from a recent low of $0.50 to nearly $4, sparking investor interest. This sharp rise caused the shares to trade at their highest levels since March this year.

Bitcoin Investment Details

Goldeneye, an investment entity associated with Greg Kidd, former chief risk officer at Ripple, plans to acquire a controlling stake in the company using 1,000 Bitcoins and supplementary cash. At current prices, the Bitcoin component alone is worth more than $105 million.

What Does Know Labs Do?
Know Labs, headquartered in Seattle, specializes in non-invasive health monitoring technologies. Their flagship product in development, KnowU, is a wearable device for continuous glucose monitoring. It allows people with diabetes to monitor blood sugar levels without needles – on the wrist, forearm, or using a patch with a replaceable sensor.

Digital Reserve Strategy Increases Know Labs Attractiveness

Key Transaction Details

  • Goldeneye purchases shares based on dividing 1,000 Bitcoin value by current stock price
  • Greg Kidd becomes CEO and Chairman after acquisition completion
  • Know Labs will retain Bitcoin as part of its reserves
  • Strategic use of cryptocurrency in corporate acquisitions

The transaction terms state that Goldeneye will purchase Know Labs common shares based on dividing the value of 1,000 Bitcoins by the current share price (at the time of agreement, it was $0.335). This model significantly increases Goldeneye’s stake in the company and demonstrates the strategic use of cryptocurrencies in corporate acquisitions. Greg Kidd will become the company’s CEO and chairman of the board after the acquisition is completed, according to an AInvest report.

Additionally, Know Labs announced that it will retain Bitcoin as part of its reserves. This form of digital reserve strategy can provide investors with indirect exposure to cryptocurrencies, which is a significant step during favorable market and regulatory conditions.

The combination of advanced healthcare technology, a strong investor, and Bitcoin orientation represents a new growth impulse for Know Labs and signals broader cryptocurrency adoption beyond the financial sector.

xlubecx

Written by

xlubecx